BioWorld Science

July 10, 1998

View Archived Issues

An overview of antiviral intervention strategies for HIV therapy

Read More

Lysostaphin: effective in rabbits with aortic valve endocarditis due to MRSA

Read More

Chiron updates HIV product development

Read More

NeoPharm scales up IL13-PE38QQR manufacturing

Read More

Findings on Atlantic's 2-5A antisense compound targeting telomerase published

Read More

New nonfeminizing estrogens with radical-scavenging activity

Read More

IL-4 fusion toxin shows potent antitumor activity in murine model of KS

Read More

Enzo discovery paves the way for antisense therapy of AIDS

Read More

Anti-HIV peptide T-22 acts as a CXCR4 receptor antagonist

Read More

AMD-3100: a potent chemokine CXCR4 antagonist enters clinical testing

Read More

French group develops new inhibitors of HIV-1 protease dimerization

Read More

Anti-HIV activity demonstrated for Teijin's antioxidant

Read More

Dong-A carbapenem undergoes pharmacokinetic evaluation in rats

Read More

Magainin publishes preclinical data for squalamine

Read More

European marketing application submitted for RenaGel

Read More

Gene Logic to acquire OncorMed

Read More

Allergan signs collaborative agreement with Santen for brimonidine

Read More

FDA grants fast track status to Miravant's Purlytin

Read More

New hormonal agents discovered by Ligand

Read More

GABA-A receptor modulators discovered by NeuroSearch

Read More

Dermatological agents in development at Galderma

Read More

Novartis presents new protein kinase inhibitors for cancer, psoriasis

Read More

Korean investigators design effective and safe agents for HBV

Read More

Intensive therapy for type I diabetes may increase cardiovascular disease risk

Read More

VALUE study now under way in Canada

Read More

AIDS vaccine combination is safe and immunogenic in seronegative volunteers

Read More